Article
05 Apr 2016
Foreign Filing License in a Nutshell
AUTHORS CONTENT
Article
29 Feb 2016
II Ca-Be-lly Or Not II Ca-Be-lly: Is The Famous Cabilly II Antibody Patent Near Extinction?
Article
12 Jan 2016
Nutter Attorneys Author Guest Post "Who Owns Your Brain According To The Contract You Signed" On MassBioHQ Blog
Article
20 Aug 2015
Latest In The § 101 Saga: Sequenom Requests En Banc Rehearing, Indicating Biomedical Research Will Be Stymied Otherwise
Article
03 Aug 2015
Update Your USPTO Filing Templates – There's A New Commissioner
Article
17 Jul 2015
Federal Circuit Finds Sequenom's Diagnostics Patent Claims Patent Ineligible Subject Matter Under Mayo
Article
15 Jun 2015
Federal Circuit Finds Sequenom's Diagnostics Patent Claims Patent Ineligible Subject Matter Under Mayo
Article
19 Jan 2015
IP Bulletin, January 2015
Article
14 Aug 2014
FDA Issues Draft Guidance On Regulatory Exclusivity For Biologics
Article
16 Jul 2014
Konstantin Linnik Blogs For Massbiohq On Best Practices In Protecting And Exploiting Intellectual Property
Article
21 May 2014
FDA Issues Draft Guidance On How To Demonstrate Biosimilarity
Article
19 Nov 2013
IP Bulletin, November 2013
Article
01 Jul 2013
The Myriad Ruling: Six Points Every Biotech CEO Must Consider
Article
17 Jun 2013
Supreme Court Unanimously Rules That "Gene Patents" Are Invalid
Article
27 Mar 2013
Functional Claim Language – To Infringe, Must The Device Be Designed To Perform The Function, Or Just Be Capable Of Performing The Function? (IP Bulletin, March 2013)
Article
16 Oct 2012
PPACA: What’s Next For Life Sciences Companies
Article
19 Sep 2012
Life Sciences Law360 Publishes "PPACA: What’s Next For Life Sciences Companies"
Article
11 Jul 2012
The US Health Care Law: What’s Next For Stakeholders
Article
05 Apr 2012
Supreme Court Remands "Myriad" For Reconsideration In Light Of "Mayo"
Article
26 Mar 2012
Supreme Court Holds Prometheus’ Diagnostic Method Claim Unpatentable